- Home
- BCAX vs MAX Comparison
BCAX vs MAX Comparison
Compare BCAX & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- MAX
- Stock Information
- Founded
- BCAX 2018
- MAX 2014
- Country
- BCAX United States
- MAX United States
- Employees
- BCAX N/A
- MAX N/A
- Industry
- BCAX
- MAX Industrial Machinery/Components
- Sector
- BCAX
- MAX Industrials
- Exchange
- BCAX NYSE
- MAX Nasdaq
- Market Cap
- BCAX 670.9M
- MAX 582.4M
- IPO Year
- BCAX 2024
- MAX 2020
- Fundamental
- Price
- BCAX $9.32
- MAX $10.66
- Analyst Decision
- BCAX Strong Buy
- MAX Buy
- Analyst Count
- BCAX 7
- MAX 7
- Target Price
- BCAX $29.17
- MAX $17.21
- AVG Volume (30 Days)
- BCAX 1.4M
- MAX 382.8K
- Earning Date
- BCAX 08-16-2025
- MAX 07-30-2025
- Dividend Yield
- BCAX N/A
- MAX N/A
- EPS Growth
- BCAX N/A
- MAX N/A
- EPS
- BCAX N/A
- MAX 0.28
- Revenue
- BCAX N/A
- MAX $1,002,364,000.00
- Revenue This Year
- BCAX N/A
- MAX $24.09
- Revenue Next Year
- BCAX N/A
- MAX $11.18
- P/E Ratio
- BCAX N/A
- MAX $38.36
- Revenue Growth
- BCAX N/A
- MAX 148.62
- 52 Week Low
- BCAX $7.80
- MAX $7.33
- 52 Week High
- BCAX $28.09
- MAX $20.91
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- MAX 55.12
- Support Level
- BCAX N/A
- MAX $10.70
- Resistance Level
- BCAX N/A
- MAX $11.13
- Average True Range (ATR)
- BCAX 0.00
- MAX 0.33
- MACD
- BCAX 0.00
- MAX -0.06
- Stochastic Oscillator
- BCAX 0.00
- MAX 41.42
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.